Sign inJoin waitlistJoin the waitlist

LC

Laura Chow

Physician · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
2025–Present

University of Colorado School of Medicine
2002–2004
Internal Medicine
1999–2002
UNIV OF BRITISH COLUMBIA, VANCOUVER
1995–1999

Research

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 7,953 citations
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Head and Neck Cancer
Review · New England Journal of Medicine · 2020 · Sole author · 1,697 citations

Christine Baik
12 papers
RD
Rafael Santana Davila
11 papers
Scott Gettinger
11 papers
Keith Eaton
10 papers
Ross Camidge
10 papers
Hossein Borghaei
9 papers
Julie Brahmer
9 papers
Renato Martins
9 papers
Cristina Rodriguez
8 papers
Gail Eckhardt
8 papers
NR
Naiyer Rizvi
8 papers
Ranee Mehra
8 papers

Grants

Defining the Features of T Cell Response to Tumor and Self-Antigens as Predictors of Response to Checkpoint Therapy
National Cancer Institute · R01
PI · $2.2M · Benaroya Research Inst at Virginia Mason
2019–2025

Clinical trials

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies
Principal investigator · Completed · Phase 1, Phase 2
MedImmune LLC
2014–2020
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).
Principal investigator · Completed · Phase 1
MedImmune LLC
2014–2021
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
Principal investigator · Completed · Phase 1
University of Washington
2011–2015
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Principal investigator · Completed · Phase 1
University of Washington
2011